Skip to content

Mushroom Ingestion Study

Mushroom Ingestion Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04257201
Enrollment
7
Registered
2020-02-05
Start date
2020-08-15
Completion date
2021-05-21
Last updated
2024-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diet, Healthy

Keywords

Mediterranean, Mushrooms, Metabolomics

Brief summary

The investigators propose to determine the effect of consuming 0, 1 or 2 servings of white button (Agaricus bisporus; most popular, lower ergothioneine) or yellow oyster (Pleurotus citrinopileatus; higher ergothioneine) mushrooms on postprandial changes in plasma levels and urinary excretions of mushroom-specific compounds.

Detailed description

The investigators hypothesize that consuming different mushroom varieties will elicit distinct postprandial nutrimetabolomic profiles in the plasma and urine and that the amount of metabolites present will increase with the servings of mushrooms. Measuring ergothioneine in the plasma will provide a quantitative outcome to document the postprandial responses to consuming the test meals. The nutrimetabolomic related outcomes are exploratory and have not been documented in human research.

Interventions

OTHERYellow Oyster -- 84 g

Participants will consume the standardized test day salad plus 84 g (raw weight) mushrooms. Mushrooms will be cooked prior to being served

OTHERYellow Oyster -- 168 g

Participants will consume the standardized test day salad plus 168 g (raw weight) mushrooms. Mushrooms will be cooked prior to being served

OTHERWhite button -- 84 g

Participants will consume the standardized test day salad plus 84 g (raw weight) mushrooms. Mushrooms will be cooked prior to being served

OTHERWhite button -- 168 g

Participants will consume the standardized test day salad plus 168 g (raw weight) mushrooms. Mushrooms will be cooked prior to being served

OTHERControl

Participants will consume the standardized test day salad only

Sponsors

Mushroom Council
CollaboratorOTHER
Purdue University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
SINGLE (Investigator)

Intervention model description

For this randomized crossover study, subjects will consume 5 test meals varying in mushroom content, each separated by a minimum of 10 days (Figure 1). For 3 days prior to each testing day participants will be provided with and instructed to exclusively consume a low-antioxidant run-in diet (low fruit, vegetable, and spice diet) to minimize background concentrations of potential test food-derived compounds of interest. On test days, participants will consume a standardized mixed-macronutrient meal (500 kcal, 75g CHO, 15g Protein, 15g Fat) containing 1) no mushrooms (control), 2) 84 g of raw white button mushrooms served cooked; 3) 168 g of raw white button mushrooms served cooked; 4) 84 g of raw yellow oyster mushrooms served cooked; or 5) 168 g of raw yellow oyster mushrooms served cooked. Between each run-in diet/testing period, participants will consume their usual, unrestricted self-selected diets for a minimum of 7 days.

Eligibility

Sex/Gender
ALL
Age
30 Years to 69 Years
Healthy volunteers
Yes

Inclusion criteria

* Male or female; * age 30-69 y; * BMI: 25.0-34.9 kg/m2; * Not severely or extremely depressed (Beck's Depression Inventory score ≤30) * Total cholesterol \<240 mg/dL, low-density lipoprotein cholesterol \<160 mg/dL, triglycerides \<400 mg/dL, fasting glucose \<110 mg/dL; * Systolic/diastolic blood pressure \<140/90 mm Hg; * Body weight stable for 3 months prior (± 3 kg); * Stable physical activity regimen 3 months prior; * Medication use stable for 6 months prior; * Non-smoking; * Non-diabetic; * Not acutely ill; * Females not pregnant or lactating; * Participants must be willing and able to consume the prescribed diets and travel to testing facilities.

Exclusion criteria

* BMI \<25 or \>35; * Severely depressed (Beck's Depression Inventory score \>30); * Total cholesterol \>240 mg/dL, low-density lipoprotein cholesterol \>160 mg/dL, triglycerides \>400 mg/dL, fasting glucose \>110 mg/dL; * Body weight changes in previous 3 months (±3 kg); * Changes in physical activity regimen in the previous 3 months; * Medication changes in the previous 6 months; * Smoking; * Diabetic; * Acute illness; * Pregnant or lactating; * Allergic to mushrooms

Design outcomes

Primary

MeasureTime frameDescription
Change in plasma glucose5 hoursPlasma will be assessed for glucose values prior to salad consumption and in response to the test day meal
Change in plasma insulin5 hoursPlasma will be assessed for insulin values prior to salad consumption and in response to the test day meal
Plasma metabolomics5 hoursPlasma will be assessed for metabolomics (i.e. ergothioneine) via reverse phase liquid chromatography/mass spectrometry
Plasma ergothioneine5 hoursPlasma will be assessed for ergothioneine concentration, a compound unique to mushrooms
Plasma triglycerides5 hoursPlasma will be assessed for triglyceride values at the time of salad consumption and at each hour for 5 hours after salad consumption

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026